1-20 of 25
Antonio Ledda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma

Clinical Trials & Observations Brief Report
Mattia D’Agostino, Giuseppe Bertuglia, Delia Rota-Scalabrini, Angelo Belotti, Sonia Morè, Paolo Corradini, Stefania Oliva, Antonio Ledda, Mariella Grasso, Vincenzo Pavone, Sonia Ronconi, Iolanda Donatella Vincelli, Stelvio Ballanti, Cristina Velluti, Claudia Cellini, Alessandro Gozzetti, Angelo D. Palmas, Barbara Gamberi, Katia Mancuso, Laura Paris, Renato Zambello, Maria Teresa Petrucci, Benedetto Bruno, Pellegrino Musto, Francesca Gay
Journal: Blood
Blood (2024) 143 (7): 592–596.
https://doi.org/10.1182/blood.2023022080
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of Gain and Amplification of 1q in Newly Diagnosed Multiple Myeloma Patients Receiving Carfilzomib-Based Treatment in the Forte Trial

Mattia D'Agostino, MD, Marina Ruggeri, Sara Aquino, Nicola Giuliani, Maddalena Arigoni, Massimo Gentile, Martina Olivero, Iolanda Donatella Vincelli, Andrea Capra, Chiara Mussatto, Antonio Ledda, Paola Tacchetti, Caterina Musolino, Claudia Cellini, Francesca Patriarca, Stelvio Ballanti, Raffaele Calogero, Pellegrino Musto, Mario Boccadoro, Francesca Gay, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–40.
https://doi.org/10.1182/blood-2020-137060
Published: 2020
Journal Articles

Identification of a Predictive Pre-Chemotherapy Score for Febrile Neutropenia - the Fnipi INDEX

Marco Sanna, Giovanni Caocci, MD, Antonio Ledda, Elisabetta Belardinelli, Pietro Garau, Alessandro Fanni, MD, Claudio Romani, Giorgio La Nasa, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-134659
Published: 2020
Journal Articles

Minimal Residual Disease Evaluation By Multiparameter Flow Cytometry and Next Generation Sequencing in the Forte Trial for Newly Diagnosed Multiple Myeloma Patients

Stefania Oliva, Elisa Genuardi, Angelo Belotti, Pio Manlio Mirko Frascione, Monica Galli, Andrea Capra, Massimo Offidani, Federico Vozella, Renato Zambello, Daniel Auclair, Agostina Siniscalchi, Jennifer Yesil, Ombretta Annibali, Ilan M. Kirsch, Simona Caltagirone, Allison P. Jacob, Stelvio Ballanti, Angelo D. Palmas, Antonio Ledda, Paolo Corradini, Paola Omedé, Michele Cavo, Pellegrino Musto, Mario Boccadoro, Francesca Gay, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4322.
https://doi.org/10.1182/blood-2019-124645
Published: 2019
Journal Articles

Carfilzomib-Lenalidomide-Dexamethasone (KRd) Induction-Autologous Transplant (ASCT)-Krd Consolidation Vs KRd 12 Cycles Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Induction-ASCT-KCd Consolidation: Analysis of the Randomized Forte Trial in Newly Diagnosed Multiple Myeloma (NDMM)

Francesca Gay, MD, Chiara Cerrato, MD, Delia Rota Scalabrini, MD, Monica Galli, MD, Angelo Belotti, MD, Elena Zamagni, MD, Antonio Ledda, MD, Mariella Grasso, MD, Emanuele Angelucci, MD, Anna Marina Liberati, MD, Patrizia Tosi, MD, Francesco Pisani, MD, Stefano Spada, Ombretta Annibali, MD, Anna Baraldi, MD, Paola Omedé, Piero Galieni, MD, Rita Rizzi, MD, Norbert Pescosta, MD, Sonia Ronconi, MD, Donatella Vincelli, MD, Anna Maria Cafro, MD, Massimo Offidani, MD, Antonio Palumbo, MD, Pellegrino Musto, MD, Michele Cavo, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 121.
https://doi.org/10.1182/blood-2018-99-112093
Published: 2018
Journal Articles

A Randomized Study of Carfilzomib-Lenalidomide-Dexamethasone Vs Carfilzomib-Cyclophosphamide-Dexamethasone Induction in Newly Diagnosed Myeloma Patients Eligible for Transplant: High Efficacy in High- and Standard-Risk Patients

Francesca Maria Gay, Delia Rota Scalabrini, MD, Angelo Belotti, MD, Monica Galli, MD PhD, Elena Zamagni, MD, Massimo Offidani, MD, Stefania Oliva, MD, Vittorio Montefusco, MD, Renato Zambello, MD, Antonio Ledda, MD, Mariella Grasso, MD, Sara Aquino, MD, Fabrizio Esma, Patrizia Tosi, MD, Francesco Pisani, MD, Ombretta Annibali, Anna Marina Liberati, Anna Baraldi, MD, Piero Galieni, MD, Giorgina Specchia, MD, Norbert Pescosta, MD, Katia Mancuso, MD, Laura Paris, MD, Rossella Ribolla, MD, Valentina Coha, MD, Antonio Palumbo, MD, Pellegrino Musto, MD, Michele Cavo, MD, Mario Boccadoro
Journal: Blood
Blood (2017) 130 (Supplement 1): 4541.
https://doi.org/10.1182/blood.V130.Suppl_1.4541.4541
Published: 2017
Journal Articles

Prognostic Implication of Somatic Mutations By Next Generation Sequencing: An Analysis from the Mmrf Commpass Study in Newly Diagnosed Multiple Myeloma Patients

Mattia D'Agostino, MD, Stefania Oliva, Alessandra Larocca, Stefano Spada, Manuela Gambella, Mary DeRome, Michele Cavo, Massimo Aglietta, Massimo Offidani, MD, Jennifer Yesil, MS, Daniela Oddolo, Chiara Cerrato, Giuseppe Rossi, MD, Antonio Ledda, Letizia Canepa, Mariella Grasso, Robert Foa', Daniel Auclair, Pellegrino Musto, Andrea Evangelista, MSc, Francesca Gay, Antonio Palumbo, MD, Mario Boccadoro
Journal: Blood
Blood (2016) 128 (22): 2079.
https://doi.org/10.1182/blood.V128.22.2079.2079
Published: 2016
Journal Articles

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Valeria Magarotto, Sara Bringhen, Massimo Offidani, Giulia Benevolo, Francesca Patriarca, Roberto Mina, Antonietta Pia Falcone, Lorenzo De Paoli, Giuseppe Pietrantuono, Silvia Gentili, Caterina Musolino, Nicola Giuliani, Annalisa Bernardini, Concetta Conticello, Stefano Pulini, Giovannino Ciccone, Vladimír Maisnar, Marina Ruggeri, Renato Zambello, Tommasina Guglielmelli, Antonio Ledda, Anna Marina Liberati, Vittorio Montefusco, Roman Hajek, Mario Boccadoro, Antonio Palumbo
Journal: Blood
Blood (2016) 127 (9): 1102–1108.
https://doi.org/10.1182/blood-2015-08-662627
Published: 2016
Includes: Supplemental data
Journal Articles

Doublet Vs Triplet Lenalidomide-Containing Regimens in Newly Diagnosed Myeloma Patients, Younger or Older Than 75 Years: Subgroup Analysis of a Phase III Study

Valeria Magarotto, MD, Sara Bringhen, MD, Pellegrino Musto, MD, Massimo Offidani, MD, Anna Marina Liberati, MD, Ludek Pour, MD, Giulia Benevolo, MD, Mariella Genuardi, MD, Caterina Musolino, Antonio Ledda, MD, Daniela Oddolo, PhD, Lorenzo De Paoli, MD, Francesca Patriarca, MD, Antonietta Pia Falcone, MD, Isola Caratozzolo, Renato Zambello, MD, Maide Cavalli, MD, Silvia Gentili, MD, Roman Hajek, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2014) 124 (21): 2110.
https://doi.org/10.1182/blood.V124.21.2110.2110
Published: 2014
Journal Articles

Bendamustine, Bortezomib and Dexamethasone (BVD) in Patients with Relapsed-Refractory Multiple Myeloma (MM): Updated Results of a Multicenter Phase II Study

Massimo Offidani, MD, Laura Maracci, Laura Corvatta, Liberati Anna Marina, Stelvio Ballanti, MD, Imma Attolico, Patrizia Caraffa, Francesco Alesiani, Tommaso Caravita di Toritto, Silvia Gentili, Patrizia Tosi, Marino Brunori, Daniele Derudas, MD, Antonio Ledda, Alessandro Gozzetti, Claudia Cellini, MD, Lara Malerba, Anna Mele, Stefano Felici, Sara Galimberti, MD PhD, Patrizia Mondello, Stefano Pulini, Ugo Coppetelli, Paolo Fraticelli, Rita Rizzi, Pietro Leoni
Journal: Blood
Blood (2014) 124 (21): 4734.
https://doi.org/10.1182/blood.V124.21.4734.4734
Published: 2014
Journal Articles

Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM)

Massimo Offidani, Laura Corvatta, Laura Maracci, Anna Marina Liberati, Stelvio Ballanti, Immacolata Attolico, Patrizia Caraffa, Francesco Alesiani, Tommaso Caravita di Toritto, Silvia Gentili, Patrizia Tosi, Marino Brunori, Daniele Derudas, MD, Antonio Ledda, Alessandro Gozzetti, Claudia Cellini, Lara Malerba, Anna Mele, Alessandro Andriani, Sara Galimberti, Patrizia Mondello, Stefano Pulini, Ugo Coppetelli, Paolo Fraticelli, Attilio Olivieri, Pietro Leoni
Journal: Blood
Blood (2013) 122 (21): 1974.
https://doi.org/10.1182/blood.V122.21.1974.1974
Published: 2013
Journal Articles

A Randomized Phase 3 Trial Of Melphalan-Lenalidomide-Prednisone (MPR) Or Cyclophosphamide-Prednisone-Lenalidomide (CPR) Vs Lenalidomide Plus Dexamethsone (Rd) In Elderly Newly Diagnosed Multiple Myeloma Patients

Antonio Palumbo, MD, Valeria Magarotto, Sara Bringhen, MD, Massimo Offidani, MD, Giuseppe Pietrantuono, MD, Anna Marina Liberati, MD, Giulia Benevolo, MD, Antonio Ledda, MD, Milena Gilestro, Monica Galli, MD, Francesca Patriarca, MD, Mariella Genuardi, MD, Nicola Giuliani, MD, Renato Zambello, MD, Adam Zdenek, Alessia La Fauci, MD, Paolo Corradini, Antonietta Pia Falcone, MD, Caterina Musolino, MD, Davide Rossi, MD, Ph.D., Patrizia Caraffa, MD, Pellegrino Musto, MD, Federica Cavallo, MD, Roman Hajek, MD, PhD, Mario Boccadoro, MD
Journal: Blood
Blood (2013) 122 (21): 536.
https://doi.org/10.1182/blood.V122.21.536.536
Published: 2013
Journal Articles

Bortezomib-Thalidomide-Dexamethasone Incorporated Into Autotransplantation Is Associated with More Favorable Outcomes After Relapse in Comparison with Thalidomide-Dexamethasone Plus Autotransplantation in Multiple Myeloma

Michele Cavo, MD, Monica Galli, MD, Lucia Pantani, MD, Francesco Di Raimondo, MD, Claudia Crippa, MD, Massimo Offidani, MD, Elena Zamagni, MD, Vittorio Montefusco, MD, Franco Narni, MD, Annalisa Pezzi, Antonio Spadano, MD, Norbert Pescosta, MD, Paola Tacchetti, MD, Luca Baldini, MD, Antonio Ledda, MD, Claudia Cellini, MD, Tommaso Caravita, MD, Antonietta Falcone, MD, Chiara Nozzoli, MD, Renato Zambello, MD, Luciano Masini, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2012) 120 (21): 4210.
https://doi.org/10.1182/blood.V120.21.4210.4210
Published: 2012
Journal Articles

Ten Year-Long Term Survival After up-Front Autologous Stem Cell Transplantation in Multiple Myeloma: Results From Two Prospective Clinical Trials

Elena Zamagni, MD, Francesco Di Raimondo, MD, Francesca Patriarca, Patrizia Tosi, Annalisa Pezzi, Claudia Cellini, Paola Tacchetti, MD, Sonia Ronconi, Silvestro Volpe, Lucia Pantani, MD, Lucio Catalano, Mauro Fiacchini, Emanuele Angelucci, Luciano Masini, Alessandro Gozzetti, Piero Galieni, Beatrice Zannetti, Franco Narni, Annamaria Brioli, Carolina Terragna, PhD, Antonio Lazzaro, Katia Mancuso, Catello Califano, Antonio Ledda, Nicoletta Testoni, Michele Baccarani, MD, Michele Cavo, MD
Journal: Blood
Blood (2012) 120 (21): 594.
https://doi.org/10.1182/blood.V120.21.594.594
Published: 2012
Journal Articles

Superior Complete Response Rate (CR) and Progression-Free Survival (PFS) with Bortezomib-Thalidomide-Dexamethasone (VTD) Versus Thalidomide-Dexamethasone (TD) As Consolidation Therapy After Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM)

Michele Cavo, MD, Lucia Pantani, MD, Francesca Patriarca, MD, Maria Teresa Petrucci, Monica Galli, MD, Francesco Di Raimondo, MD, Giuseppe Rossi, MD, Antonio Palumbo, MD, Paola Tacchetti, MD, Massimo Offidani, MD, Vittorio Montefusco, MD, Franco Narni, MD, Tonino Spadano, MD, Claudia Cellini, MD, Norbert Pescosta, MD, Luca Baldini, MD, Antonio Ledda, MD, Tommaso Caravita Di Toritto, MD, Annalisa Pezzi, Statistician, Antonietta Falcone, MD, Chiara Nozzoli, MD, Renato Zambello, MD, Luciano Masini, MD, Filippo Gherlinzoni, MD, Maria Concetta Petti, MD, Daniele Derudas, MD, Stelvio Ballanti, MD, Valerio De Stefano, MD, Michele Baccarani, MD
Journal: Blood
Blood (2011) 118 (21): 1871.
https://doi.org/10.1182/blood.V118.21.1871.1871
Published: 2011
Journal Articles

Prognostic Impact of Cytogenetic Abnormalities On Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated with Thalidomide-Dexamethasone Incorporated Into Double Autologous Stem-Cell Transplantation: An Analysis of 593 Patients

Elena Zamagni, Nicoletta Testoni, Carolina Terragna, Paola Tacchetti, Mauro Fiacchini, Francesca Patriarca, Patrizia Tosi, Francesco Di Raimondo, Giulia Marzocchi, Maria Teresa Petrucci, Lucio Catalano, Sandra Durante, Silvestro Volpe, Monica Galli, Luciano Masini, Antonio Ledda, Annamaria Brioli, Claudia Crippa, Alessandro Gozzetti, Franco Narni, Catello Califano, Claudia Cellini, Sara Bringhen, Giuliana Leopardi, Lucia Pantani, Michela Ceccolini, Massimo Offidani, Giulia Perrone, Beatrice Anna Zannetti, Michele Baccarani, MD, Michele Cavo
Journal: Blood
Blood (2010) 116 (21): 3562.
https://doi.org/10.1182/blood.V116.21.3562.3562
Published: 2010
Journal Articles

Molecular Remission After Bortezomib-Thalidomide-Dexamethasone Compared with Thalidomide-Dexamethasone as Consolidation Therapy Following Double Autologous Transplantation for Multiple Myeloma: Results of a Qualitative and Quantitative Analysis

Carolina Terragna, Elena Zamagni, Maria Teresa Petrucci, Sandra Durante, Francesca Patriarca, Franco Narni, Claudia Crippa, Ausilia Gorgone, Tommaso Caravita, Giulia Perrone, Chiara Nozzoli, Luciano Masini, Vincenzo Callea, Immacolata Attolico, Claudia Cellini, Sara Bringhen, Antonio Ledda, Vittorio Montefusco, Marina Martello, Giovanni Martinelli, Michele Baccarani, Michele Cavo
Journal: Blood
Blood (2010) 116 (21): 861.
https://doi.org/10.1182/blood.V116.21.861.861
Published: 2010
Journal Articles

A Phase III Study of Double Autotransplantation Incorporating Bortezomib-Thalidomide-Dexamethasone (VTD) or Thalidomide-Dexamethasone (TD) for Multiple Myeloma: Superior Clinical Outcomes with VTD Compared to TD.

Michele Cavo, M.D., Paola Tacchetti, M.D., Francesca Patriarca, M.D., Maria Teresa Petrucci, M.D., Lucia Pantani, M.D., Monica Galli, M.D., Francesco Di Raimondo, M.D., Claudia Crippa, M.D., Sara Bringhen, M.D., Massimo Offidani, M.D., Franco Narni, M.D., Vittorio Montefusco, M.D., Elena Zamagni, M.D., Tonino Spadano, M.D., Norbert Pescosta, M.D., Luca Baldini, M.D., Claudia Cellini, M.D., Tommaso Caravita, M.D., Antonio Ledda, M.D., Antonietta Falcone, M.D., Patrizia Tosi, M.D., Chiara Nozzoli, M.D., Renato Zambello, M.D., Luciano Masini, M.D., Paola Agostini, M.D., Mauro Fiacchini, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2009) 114 (22): 351.
https://doi.org/10.1182/blood.V114.22.351.351
Published: 2009
Journal Articles

Incorporation of Thalidomide-Dexamethasone (Thal-Dex) into up-Front Double Autologous Stem-Cell Transplantation (ASCT) for multiple Myeloma: Final analysis of phase II “Bologna 2002” Study.

Elena Zamagni, M.D., Nicoletta Testoni, B.S., Carolina Terragna, B.S., Paola Tacchetti, M.D., Chiara Nicci, B.S., Patrizia Tosi, M.D., Mauro Fiacchini, M.D., Francesca Patriarca, M.D., Francesco Di Raimondo, M.D., Lucio Catalano, M.D., Francesco Casulli, M.D., Silvestro Volpe, M.D., Luciano Masini, M.D., Antonio Ledda, M.D., Annamaria Brioli, M.D., Delia Cangini, M.D., Alessandro Gozzetti, M.D., Catello Califano, M.D., Claudia Cellini, M.D., Affra Carubelli, M.D., Alessandro Petrucci, M.D., Giuliana Leopardi, M.D., Lucia Pantani, M.D., Michela Ceccolini, M.D., Massimo Offidani, M.D., Giulia Perrone, M.D., Michele Baccarani, M.D., Michele Cavo, M.D.
Journal: Blood
Blood (2009) 114 (22): 349.
https://doi.org/10.1182/blood.V114.22.349.349
Published: 2009
Journal Articles

A Phase III Study of Enoxaparin vs Aspirin vs Low-Dose Warfarin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Thalidomide Based-Regimens.

Antonio Palumbo, MD, Michele Cavo, Sara Bringhen, Maide Cavalli, Francesca Patriarca, Davide Rossi, Paola Tacchetti, Norbert Pescosta, Claudia Crippa, Monica Galli, Tonino Spadano, Angelo Michele Carella, Tommaso Caravita, Claudia Cellini, Antonio Ledda, Francesco Pisani, Jacopo Peccatori, Francesca Elice, Andrea Nozza, Valerio De Stefano, Luca De Rosa, Anna Marina Liberati, Fabrizio Ciambelli, Giovanni De Sabbata, Lucio Catalano, Alessandra Larocca, Fortunato Morabito, Elena Zamagni, Massimo Offidani, Patrizia Tosi, Mario Boccadoro
Journal: Blood
Blood (2009) 114 (22): 492.
https://doi.org/10.1182/blood.V114.22.492.492
Published: 2009